Mindray Announces its Recent Filing of Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
SHENZHEN, China, May 21, 2013 /PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that on April 8, 2013, it filed with the Securities and Exchange Commission an Annual Report on Form 20-F that included audited financial statements for the year ended December 31, 2012. An electronic version of Mindray's Annual Report on Form 20-F is available on Mindray's investor relations website at http://ir.mindray.com or http://www.sec.gov.
Investors may obtain a printed copy of Mindray's audited financial statements free of charge by contacting Mindray Investor Relations either by phone, email or in writing at the address below:
ATTN: Investor Relations
Keji 12th Road South, High-tech Industrial Park
Nanshan, Shenzhen 518057
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey, and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit http://ir.mindray.com.
For investor and media inquiries, please contact:
In the U.S:
Western Bridge, LLC
Mindray Medical International Limited
SOURCE Mindray Medical International Limited